Trump’s Surgeon General Pick Built Name Fighting HIV And Opioids In Indiana

By Emily Forman, Side Effects Public Media July 7, 2017 Several weeks before President Donald Trump nominated Indiana’s state health commissioner Jerome Adams to be the next U.S. surgeon general, Adams toured the Salvation Army Harbor Light detox center in Indianapolis, the only treatment facility in the state for people without insurance. Adams’ supporters say…

Continue Reading →

New On The Streets: Drug For Nerve Pain Boosts High For Opioid Abusers

By Carmen Heredia Rodriguez July 6, 2017 ATHENS, Ohio — On April 5, Ciera Smith sat in a car parked on the gravel driveway of the Rural Women’s Recovery Program here with a choice to make: go to jail or enter treatment for her addiction. Smith, 22, started abusing drugs when she was 18, enticed…

Continue Reading →

Lots Of Boos In California For Senate Health Bill

By Anna Gorman and Kellen Browning and Ana B. Ibarra June 23, 2017 California politicians, medical providers and consumer advocates served up harsh critiques of the newly unveiled Senate health care bill Thursday, arguing that the proposed legislation could make coverage inaccessible for poor residents while cutting taxes on the rich. “This bill is not…

Continue Reading →

8 Deadly Mistakes To Avoid When Building Your HIV Pharmacy- LIVE CE Webinar Event

The American College of Apothecaries is hosting a live CE Webinar event on Tuesday April 11th at 11am CST The webinar will be  8 Deadly Mistakes To Avoid When Building Your HIV Pharmacy presented by Michelle J Sherman, RPh, FASCP,FACA,AAHIVP This activity will bring to light eight areas that are essential to a thriving successful…

Continue Reading →

Justice Department Joins Lawsuit Alleging Massive Medicare Fraud By UnitedHealth

By Fred Schulte March 28, 2017 The Justice Department has joined a California whistleblower’s lawsuit that accuses insurance giant UnitedHealth Group of fraud in its popular Medicare Advantage health plans. Justice officials filed legal papers to intervene in the suit, first brought by whistleblower James Swoben in 2009, on Friday in federal court in Los…

Continue Reading →

First HIV Drug Approved By FDA Turns 30

This past week, March 19th to be exact was the 30th anniversary of the day when FDA approved AZT (Zidovudine) brand name Retrovir, the first drug to treat HIV/AIDS. This was 6 years after the first AIDS cases were reported to CDC in June 5th 1981 MMWR report, after cases were reported among healthy gay…

Continue Reading →

To Save On Drug Costs, Insurer Wants To Steer You To ‘Preferred’ Pharmacies

By Pauline Bartolone March 9, 2017 One of California’s largest insurers has proposed a change in the benefits of commercial plans next year that would require consumers to pay more for drugs at pharmacies outside an established network. Blue Shield of California wants to create “a tiered pharmacy network” in its 2018 small- and large-group…

Continue Reading →

Trump, Dems Look For Common Ground On Drug Prices

By Sarah Jane Tribble For years, congressional Democrats have tried to pass legislation to allow Medicare to negotiate prescription drug prices for millions of beneficiaries. Now, they believe they have a not-so-secret weapon: President Donald Trump. On Wednesday, U.S. Reps. Elijah Cummings (D-Md.) and Peter Welch (D-Vt.) met privately for about an hour with Trump…

Continue Reading →

Five Ways The GOP Health Bill Would Reverse Course From The ACA

By Julie Rovner After literally years of promises, House Republicans finally have a bill they say will “repeal and replace” the Affordable Care Act. Some conservative Republicans have derided the new proposal — the American Health Care Act — calling it “Obamacare Lite.” It keeps intact some of the more popular features of the ACA,…

Continue Reading →

Patient Advocacy Groups Rake In Donations From Pharma

By Emily Kopp March 1, 2017 High-profile advocacy groups for patients with cancer, Alzheimer’s, HIV and other diseases almost always accept funding from pharmaceutical firms, and many fail to report any contributions, new research shows. At least 83 percent of the nation’s 104 largest patient advocacy groups take contributions from the drug, medical device and…

Continue Reading →

Page 2 of 22